| Aug 22, 2016 |
FDA Decision Boosts Beta-O2's Artificial Pancreas |
| Dec 8, 2015 |
BioControl INOVATE-HF Study Discontinued Following Interim Analysis Showing Statistical Futility in the Primary Efficacy Endpoint |
| Aug 27, 2015 |
BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit System to Treat Heart Failure |
| Mar 30, 2015 |
Beta-O2 Names Dr. Yuval Avi CEO. Sherpa Innoventures Joins List of Company Investors |
| Feb 19, 2015 |
Beta-O2's ßAir Bio-Artificial Adrenal Device Shows Potential to Treat Adrenocortical Insufficiency and Other Stress-Related Disorders |
| Oct 21, 2014 |
First Patient Successfully Implanted in Safety / Efficacy Study of Beta-O2's ßAir Bio-Artificial Pancreas for Type 1 Diabetes |
| Sep 10, 2014 |
Beta-O2 Technologies Receives Grant from JDRF to Advance Clinical Development of the ßAir Bio-Artificial Pancreas as a Potential Cure for Type 1 Diabetes |
| Aug 29, 2014 |
BioControl Medical Crosses Important Enrollment Milestone in INOVATE-HF Study Evaluating CardioFit® System in Heart Failure |
| Jan 7, 2014 |
Encapsulate THIS. Nature Medicine Article on Islet Cell Encapsulation |
| Oct 29, 2013 |
Beta-O2 Technologies Presents Results of First-In-Human Transplantation of Human Islets Without Immunosuppression |
| Mar 26, 2013 |
U.S. Food and Drug Administration Approves Full Expansion of BioControl Medical's INOVATE-HF Study of its CardioFit® System for Treatment of Heart Failure |
| Dec 11, 2012 |
European Journal of Heart Failure Lauds BioControl Medical's Research on Vagus Nerve Stimulation for Treating Heart Failure |
| Dec 3, 2012 |
BioControl Medical's VNS Technology Shown Effective for Treating Epilepsy |
| Nov 8, 2012 |
Pilot Study Extension Results Indicate Long-Term Treatment Durability with BioControl Medical's CardioFit System |
| Oct 8, 2012 |
St. Jude Medical Announces Launch of its MediGuide Technology |
| Jul 11, 2012 |
BioControl Medical Gets Nod to Begin Second Phase of the INOVATE-HF Study of its CardioFit System |
| Jun 1, 2012 |
BioControl Medical's INOVATE-HF Study Design Published in the American Heart Journal |
| Jun 14, 2011 |
CerebralRx, a Spin-Off of BioControl Medical, Launches FitNeS Neuromodulation System for Treating Epilepsy |
| Apr 27, 2011 |
Trig Medical Launches LaborPro in the U.S. |
| Apr 26, 2011 |
BioControl Medical Launches its INOVATE-HF IDE Study of its CardioFit System for Heart Failure |
| Nov 3, 2010 |
BioControl Medical Obtains IDE Approval for its INOVATE-HF Study |
| Sep 21, 2010 |
Deep Breeze Launches VRIxp Pulmonary Imaging System in U.S. Emergency Departments |
| May 30, 2010 |
FDA Clears VRIxp for Aiding in Diagnosis and Patient Management |
| May 24, 2010 |
Medtronic to Invest $70m in BioControl Medical, Obtains an Option to Buy the Company |
| Sep 1, 2009 |
TransPharma Completes Phase II Trial of ViaDerm hPTH for Osteoporosis |
| Aug 21, 2009 |
Trig Medical Wants to Take Childbirth Experience on a Multimedia Trip |
| Jan 7, 2009 |
BioControl Medical's CardioFit System Obtains CE Mark |
| Dec 22, 2008 |
St. Jude Medical Acquires MediGuide for $300 Million |
| Dec 15, 2008 |
TransPharma Obtains CE Mark for its Transdermal Drug Delivery Device |
| Jun 12, 2008 |
Eli Lilly and TransPharma Announce Licensing and Development Agreement |
| Dec 13, 2007 |
MediGuide Obtains CE Mark for its Medical Positioning System and its MPS-Enabled Guided Measurement Catheter |
| Nov 29, 2007 |
QuantomiX Acquired by El-Mul Technologies |
| Aug 23, 2007 |
MediGuide Preform First-in-Man Trial with its Guided Medical Positioning System |
| Aug 9, 2007 |
Deep Breeze VRIxp Non-Invasive, Radiation Free Pulmonary Imaging System Obtains FDA Clearance |
| Jul 9, 2007 |
TransPharma Presents Positive Results of Phase I Trial of ViaDerm hPTH for Osteoporosis |
| Mar 7, 2007 |
Can-Fite Completes NIS 40 Million Private Placement |
| Mar 7, 2007 |
Procognia Raises NIS 43 Million in Tel-Aviv Stock Exchange IPO |
| Jan 8, 2007 |
BioControl Launches International, Multi-Center, Clinical Study of the CardioFit System for Heart Failure |
| Nov 12, 2006 |
CanFite BioPharma Presents Study Results of CF101 in Rheumatoid Arthritis |
| July 24, 2006 |
TransPharma Medical Completes $18 Million Series C Financing Round |
| July 12, 2006 |
Johnson & Johnson Acquires Colbar for $159m |
| May 17, 2006 |
Canfite BioPharma Completes NIS 30 Million Fund Raising |
| Apr 26, 2006 |
AMS Acquires BioControl's Miniaturo Electrical Stimulation Urology Platform |
| Mar 20, 2006 |
Stryker Corporation Acquires Sightline Technologies for $140 Million |
| Jan 24, 2006 |
CanFite Signs Cooperative R&D Agreement with th National Institute of Health |
| Sep 26, 2005 |
CanFite BioPharma Raises NIS 45 Million on the Tel-Aviv Stock Exchange |
| Sep 14, 2005 |
Revolutionary Lung Imaging Technology, Vibration Response Imaging, Obtains CE Mark |
| Aug 23, 2005 |
SightLine Technologies Raises $10 Million in Series D Financing |
| Sep 7, 2004 |
Colbar Completes $7.25 Million Series D Financing Round |
| Jun 30, 2004 |
Can-Fite Initiates Multi-Center Phase I Trial of CF101 in Combination with Chemotherapy for Various Solid Tumors |
| Mar 23, 2004 |
SightLine Technologies Receives FDA Approval for ColonoSight for Diagnosis and Treatment of Colorectal Cancer |
| Mar 8, 2004 |
Beta-O2 Technologies Raises $2 Million in Seed Financing |
| Jan 6, 2004 |
CanFite's CF101 Shown Effective in Restraining Growth of Cancerous Tumors |
| Aug 14, 2003 |
Quantomix Raises $3.5 Million in Series B Financing Round |
| Jun 11, 2003 |
CanFite BioPharma Completes $12 Million Financing Round |
| Jun 10, 2003 |
TransPharma Raises $8.9 Million in Second Round of Financing |
| Apr 13, 2003 |
Vitalife Life Sciences Ventures Closes $50 Million Fund |
